Table 3.
A synopsis of the effect of piperazine substitution or replacement on antiviral activity of 4-fluoro-substituted indole 3-glyoxamide derivatives [21]
![]() | |||
|---|---|---|---|
| Compd # | ![]() |
EC50 (nM) | CC50 (μM) |
| 15 | ![]() |
2.6 | >300 |
| 62 | ![]() |
0.56 | >300 |
| 63 | ![]() |
<0.16 | >300 |
| 64 | ![]() |
1.38 | >300 |
| 65 | ![]() |
2.60 | >300 |
| 66 | ![]() |
>50,000 | >300 |
| 67 | ![]() |
>50,000 | >300 |
| 68 | NH-CH2-CH2NH | >50,000 | >300 |
| 69 | CH3N-CH2-CH2N-CH3 | >50,000 | >300 |
| 70 | NH-CH2-CH2-CH2NH | >50,000 | >300 |
| 71 | CH3N-CH2-CH2-CH2-NCH3 | >50,000 | >300 |
| 72 | ![]() |
>50,000 | >300 |
| 73 | ![]() |
30,500 | 65 |
| 74 | ![]() |
>50,000 | >300 |











